Skip to content
GenoLensGenoLens

SMG9

Chr 19q13.31

SMG9 nonsense mediated mRNA decay factor

Aliases:
FLJ12886
MANE:
ENST00000270066.11

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Clefting

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Structural eye disease

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • Autosomal dominant deafness-onychodystrophy syndrome

    0.64
  • neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies

    0.55
  • hereditary disease

    0.41
  • Global developmental delay

    0.33
  • Abnormal cardiovascular system morphology

    0.33
  • Abnormal facial shape

    0.33
  • autism spectrum disorder

    0.33
  • Brainstem dysplasia

    0.33
  • Neurodevelopmental abnormality

    0.33
  • glioma

    0.08

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Nonsense-mediated mRNA decay factor SMG9

Involved in nonsense-mediated decay (NMD) of mRNAs containing premature stop codons (PubMed:19417104). Is recruited by release factors to stalled ribosomes together with SMG1 and SMG8 (forming the SMG1C protein kinase complex) and, in the SMG1C complex, is required for the efficient association between SMG1 and SMG8 (PubMed:19417104). Plays a role in brain, heart, and eye development (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.